CAT No: CP01908
CAS No:2592-18-9
Synonyms/Alias:Boc-L-threonine;2592-18-9;Boc-Thr-OH;N-Boc-L-threonine;N-(tert-Butoxycarbonyl)-L-threonine;MFCD00065946;SBB065846;(2S,3R)-2-((tert-butoxycarbonyl)amino)-3-hydroxybutanoicacid;(2S,3R)-2-(tert-Butoxycarbonylamino)-3-hydroxybutanoicacid;(2S,3R)-2-[(tert-butoxycarbonyl)amino]-3-hydroxybutanoicacid;Boc-L-Thr-OH;N-tert-Butoxycarbonyl-L-threonine;(2S,3R)-2-[(tert-butoxy)carbonylamino]-3-hydroxybutanoicacid;n-boc-threonine;N-TERT-BUTOXYCARBONYLTHREONINE;N-Boc-(L)-threonine;PubChem11169;AC1MC5MB;t-butyloxycarbonyl-threonine;SCHEMBL708582;t-butyloxycarbonyl-L-threonine;tert.butyloxycarbonyl-threonine;L-Threonine,N-BOCprotected;Jsp005109;CHEMBL1221956
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.